Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Sepsis a Significant factor in Covid-19 Deaths

<< Previous

Bullboard Posts

Next >>

Comment by hmmmmmmmmon Dec 20, 2021 6:49pm

107 Views

Post# 34248666

RE:Sepsis a Significant factor in Covid-19 Deaths

“The best COVID-19 care includes good sepsis care.”

This is a good find.

I too can not understand why we have abandoned any PMX/ COVID-19 testing. After 20 months of barely any Tigris patients- you'd think we would have had the time/ staff/ interest to have pursued this.

I have a faint memory of a University doing a PMX/ COVID trial in the US.. anyone else remember this or have any info I could follow up on.

<< Previous

Bullboard Posts

Next >>

They started in video game investing, now they serve high net worth traders